Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kyoso Ishida"'
Autor:
Masaki Kobayashi, Kenjiro Sawada, Akihiko Yoshimura, Misa Yamamoto, Aasa Shimizu, Kotaro Shimura, Naoko Komura, Mayuko Miyamoto, Kyoso Ishida, Tadashi Kimura
Publikováno v:
BMC Women's Health, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Denosumab is a major treatment option for patients with postmenopausal osteoporosis; however, the evidence for its use is lacking. Therefore, in this 24-month retrospective study, we aimed to evaluate the effects of switching from
Externí odkaz:
https://doaj.org/article/acb4c4a3aa69429da95e6a48c36061af
Autor:
Akihiko Yoshimura, Kenjiro Sawada, Koji Nakamura, Yasuto Kinose, Erika Nakatsuka, Masaki Kobayashi, Mayuko Miyamoto, Kyoso Ishida, Yuri Matsumoto, Michiko Kodama, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background microRNAs (miRNAs) stably exist in circulating blood and are encapsulated in extracellular vesicles such as exosomes. The aims of this study were to identify which exosomal miRNAs are highly produced from epithelial ovarian cancer
Externí odkaz:
https://doaj.org/article/19498092d15c4c37a7c88f0f1cb6f343
Autor:
Masaki Kobayashi, Kenjiro Sawada, Koji Nakamura, Akihiko Yoshimura, Mayuko Miyamoto, Aasa Shimizu, Kyoso Ishida, Erika Nakatsuka, Michiko Kodama, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura
Publikováno v:
Journal of Ovarian Research, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background microRNAs (miRNAs) stably exist in circulating blood encapsulated in extracellular vesicles such as exosomes; therefore, serum miRNAs have the potential to serve as novel cancer biomarkers. New diagnostic markers to detect high gr
Externí odkaz:
https://doaj.org/article/50a8be3262544090a67ee74dc5159838
Autor:
Yasufumi Kaneda, Jun Luo, Mitsuhiro Arisawa, Norio Nonomura, Kyoso Ishida, Yusuke Yoshikawa, Hiromichi Nagano, Koji Kitamura, Airi Ishibashi, Kotaro Saga, Keisuke Nimura, Norihiko Kawamura
A list of antibodies used in the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e2d2cd8987d68d4bf08d42692cf1ac
https://doi.org/10.1158/0008-5472.22420928.v1
https://doi.org/10.1158/0008-5472.22420928.v1
Autor:
Yasufumi Kaneda, Jun Luo, Mitsuhiro Arisawa, Norio Nonomura, Kyoso Ishida, Yusuke Yoshikawa, Hiromichi Nagano, Koji Kitamura, Airi Ishibashi, Kotaro Saga, Keisuke Nimura, Norihiko Kawamura
A list of primers used for PCR and gRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5966302a8da5b60cc54a9729a7e1a6b5
https://doi.org/10.1158/0008-5472.22420931
https://doi.org/10.1158/0008-5472.22420931
Autor:
Yasufumi Kaneda, Jun Luo, Mitsuhiro Arisawa, Norio Nonomura, Kyoso Ishida, Yusuke Yoshikawa, Hiromichi Nagano, Koji Kitamura, Airi Ishibashi, Kotaro Saga, Keisuke Nimura, Norihiko Kawamura
Androgen receptor splice variant-7 (AR-V7) is a constitutively active AR variant implicated in castration-resistant prostate cancers. Here, we show that the RNA splicing factor SF3B2, identified by in silico and CRISPR/Cas9 analyses, is a critical de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb9f4d18b156bc336c15b56775d99a8
https://doi.org/10.1158/0008-5472.c.6510788.v1
https://doi.org/10.1158/0008-5472.c.6510788.v1
Autor:
Yasufumi Kaneda, Jun Luo, Mitsuhiro Arisawa, Norio Nonomura, Kyoso Ishida, Yusuke Yoshikawa, Hiromichi Nagano, Koji Kitamura, Airi Ishibashi, Kotaro Saga, Keisuke Nimura, Norihiko Kawamura
Supplementary Figures 1-8. (1) Figure S1 shows Identification of SF3B2 as a splicing modulating factor associated with AR-V7 expression. (2) Figure S2 shows FACS analysis of gRNA against each candidate gene-transfected AR-V7-GFP cell population. (3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::316ca8647bac5339014bec2af951050a
https://doi.org/10.1158/0008-5472.22420934
https://doi.org/10.1158/0008-5472.22420934
Autor:
Naoki Sumitani, Kyoso Ishida, Kenjiro Sawada, Tadashi Kimura, Yasufumi Kaneda, Keisuke Nimura
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3580
To reveal tumor heterogeneity in ovarian cancer, we performed single-cell RNA sequencing (RNA-seq). We obtained The Cancer Genome Atlas (TCGA) survival data and TCGA gene expression data for a Kaplan–Meier plot showing the association of each tumor
Autor:
Aasa Shimizu, Tadashi Kimura, Masaki Kobayashi, Misa Yamamoto, Kyoso Ishida, Koji Nakamura, Akihiko Yoshimura, Kenjiro Sawada, Kae Hashimoto, Michiko Kodama, Mayuko Miyamoto
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports
Scientific Reports
Paclitaxel resistance is a critical challenge in ovarian cancer treatment. This study aimed to identify microRNAs (miRNAs) that modulate paclitaxel resistance for use as potential therapeutic targets in such settings. Paclitaxel-resistant cell lines
Autor:
Koji Kitamura, Keisuke Nimura, Hiromichi Nagano, Yusuke Yoshikawa, Kyoso Ishida, Mitsuhiro Arisawa, Norihiko Kawamura, Yasufumi Kaneda, Airi Ishibashi, Norio Nonomura, Kotaro Saga, Jun Luo
Publikováno v:
Cancer Research. 79:5204-5217
Androgen receptor splice variant-7 (AR-V7) is a constitutively active AR variant implicated in castration-resistant prostate cancers. Here, we show that the RNA splicing factor SF3B2, identified by in silico and CRISPR/Cas9 analyses, is a critical de